{"DataElement":{"publicId":"3124182","version":"1","preferredName":"Sarcoma Histologic And Cell Differentiation ICD-O-3 Code","preferredDefinition":"Alphanumeric code to represent the histologic classification (plus grade) for a sarcoma case.","longName":"2197683v1.0:3124055v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2197683","version":"1","preferredName":"Sarcoma Histologic Classification","preferredDefinition":"information related to the histologic classificatio of a sarcoma.","longName":"SARCOMA_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177012","version":"1","preferredName":"Sarcoma","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","longName":"Sarcoma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AD9-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEC1C908-359F-5EE5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3124055","version":"1","preferredName":"Sarcoma Histologic And Cell Differentiation ICD-O-3 Code","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004_Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The process during which young, immature (unspecialized) cells take on individual characteristics and reach their mature (specialized) form and function._Indicates the matching ICD-O-3 code for the NCI Thesaurus concept._A system of numbered categories for representation of data.","longName":"3124055v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"8900/3","valueDescription":"Rhabdomyosarcoma NOS","ValueMeaning":{"publicId":"2568836","version":"1","preferredName":"Rhabdomyosarcoma NOS","longName":"2568836","preferredDefinition":"Rhabdomyosarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90C7026C-337A-B383-E040-BB89AD4363DF","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-21","modifiedBy":"ONEDATA","dateModified":"2010-09-21","deletedIndicator":"No"},{"value":"9261/3","valueDescription":"Adamantinoma","ValueMeaning":{"publicId":"3123865","version":"1","preferredName":"Adamantinoma","longName":"3123865","preferredDefinition":"A low grade malignant tumor arising from the bones.  The tibia is the most commonly affected site.  Swelling with or without pain is the most frequently reported clinical symptom.  The vast majority of cases recur if they are not treated with radical surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adamantinoma","conceptCode":"C7644","definition":"A low grade malignant neoplasm arising from the long bones. The tibia is the most frequently affected bone site. Patients present with swelling which may or may not be associated with pain. Morphologically, it is characterized by a biphasic pattern consisting of an epithelial and an osteofibrous component. The vast majority of cases recur if they are not treated with radical surgery. In a minority of cases the tumor may metastasize to other anatomic sites including lymph nodes, lungs, liver, brain, and skeleton.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3BE6-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-F929-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8936/1","valueDescription":"Gastrointestinal stromal tumor (GIST)","ValueMeaning":{"publicId":"2568829","version":"1","preferredName":"Gastrointestinal stromal tumor (GIST)","longName":"2568829","preferredDefinition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"DWARZEL","dateModified":"2019-04-02","changeDescription":"Added Concept Code DW 04-02-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93F041AF-B4F9-887F-E040-BB89AD432016","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-31","modifiedBy":"ONEDATA","dateModified":"2010-10-31","deletedIndicator":"No"},{"value":"8931/3","valueDescription":"Low Grade Endometrial Stromal Sarcoma","ValueMeaning":{"publicId":"3123866","version":"1","preferredName":"Low Grade Endometrial Stromal Sarcoma","longName":"3123866","preferredDefinition":"denoting slow growth; indolent.: A uterine stromal sarcoma originating from the endometrium.  It is further subdivided into low grade endometrial stromal sarcoma and undifferentiated uterine sarcoma. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3C98-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE68-62B1-E040-BB89AD4341E3","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8930/3","valueDescription":"Undifferentiated Endometrial Stromal Sarcoma","ValueMeaning":{"publicId":"3123861","version":"1","preferredName":"Undifferentiated Endometrial Stromal Sarcoma","longName":"3123861","preferredDefinition":"A term used to describe cells or tissues that do not have specialized (\"mature\") structures or functions. Undifferentiated cancer cells often grow and spread quickly.: A uterine stromal sarcoma originating from the endometrium.  It is further subdivided into low grade endometrial stromal sarcoma and undifferentiated uterine sarcoma. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3B9A-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE7C-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9133//3","valueDescription":"Epithelioid hemagioendothelioma","ValueMeaning":{"publicId":"2568841","version":"1","preferredName":"Epithelioid hemagioendothelioma","longName":"2568841","preferredDefinition":"Epithelioid hemagioendothelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE90-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8804/3","valueDescription":"Epithelioid sarcoma","ValueMeaning":{"publicId":"2568844","version":"1","preferredName":"Epithelioid sarcoma","longName":"2568844","preferredDefinition":"Epithelioid sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FEA4-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9260/3","valueDescription":"Ewing's sarcoma/PNET","ValueMeaning":{"publicId":"2571087","version":"1","preferredName":"Ewing's sarcoma/PNET","longName":"2571087","preferredDefinition":"Ewing's sarcoma/peripheral neuroectodermal tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E2BC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-07-15","modifiedBy":"CAMPBELB","dateModified":"2004-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FEB8-62B1-E040-BB89AD4341E3","beginDate":"2004-07-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8963/3","valueDescription":"Extrarenal Rhabdoid Tumor","ValueMeaning":{"publicId":"3123860","version":"1","preferredName":"Extrarenal Rhabdoid Tumor","longName":"3123860","preferredDefinition":"A rhabdoid tumor which arises in the soft tissues.  It occurs in infants and children and may be associated with loss of chromosome 22.  It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrarenal Rhabdoid Tumor","conceptCode":"C6586","definition":"A rhabdoid tumor which arises in the soft tissues.  It occurs in infants and children and may be associated with loss of chromosome 22.  It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3B74-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FECC-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9240/3","valueDescription":"Extraskeletal mesenchymal chondrosarcoma","ValueMeaning":{"publicId":"2568838","version":"1","preferredName":"Extraskeletal mesenchymal chondrosarcoma","longName":"2568838","preferredDefinition":"Extraskeletal mesenchymal chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FEF4-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9231/3","valueDescription":"Extraskeletal myxoid chondrosarcoma","ValueMeaning":{"publicId":"2568837","version":"1","preferredName":"Extraskeletal myxoid chondrosarcoma","longName":"2568837","preferredDefinition":"Extraskeletal myxoid chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FF08-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9180/3","valueDescription":"Extraskeletal osteosarcoma","ValueMeaning":{"publicId":"2568839","version":"1","preferredName":"Extraskeletal osteosarcoma","longName":"2568839","preferredDefinition":"Extraskeletal osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FF1C-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8810/3","valueDescription":"Fibrosarcoma","ValueMeaning":{"publicId":"2568825","version":"1","preferredName":"Fibrosarcoma","longName":"2568825","preferredDefinition":"A malignant mesenchymal tumor affecting soft tissues and bone. It is classified as adult or infantile.  Infantile fibrosarcomas generally have a much more favorable prognosis than adult fibrosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosarcoma","conceptCode":"C3043","definition":"A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FF30-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8814/3","valueDescription":"Infantile fibrosarcoma","ValueMeaning":{"publicId":"2571010","version":"1","preferredName":"Infantile fibrosarcoma","longName":"2571010","preferredDefinition":"Infantile fibrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E26F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-07-07","modifiedBy":"CAMPBELB","dateModified":"2004-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0145-62B1-E040-BB89AD4341E3","beginDate":"2004-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8800/3","valueDescription":"Intimal Sarcoma","ValueMeaning":{"publicId":"3123928","version":"1","preferredName":"Intimal Sarcoma","longName":"3123928","preferredDefinition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intimal Sarcoma","conceptCode":"C53677","definition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4538-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0159-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9130/1","valueDescription":"Kaposiform Hemangioendothelioma","ValueMeaning":{"publicId":"3123926","version":"1","preferredName":"Kaposiform Hemangioendothelioma","longName":"3123926","preferredDefinition":"An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels.  It is often associated with hemorrhage and hemosiderin deposition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposiform Hemangioendothelioma","conceptCode":"C27510","definition":"An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels.  It is often associated with hemorrhage and hemosiderin deposition.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4512-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0181-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8890/3","valueDescription":"Leiomyosarcoma","ValueMeaning":{"publicId":"2562491","version":"1","preferredName":"Leiomyosarcoma","longName":"2562491","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C128-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-27","endDate":null,"createdBy":"PWEST","dateCreated":"2002-09-27","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0195-62B1-E040-BB89AD4341E3","beginDate":"2002-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8850/3","valueDescription":"Liposarcoma NOS","ValueMeaning":{"publicId":"2568823","version":"1","preferredName":"Liposarcoma NOS","longName":"2568823","preferredDefinition":"Liposarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-01A9-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8811/3","valueDescription":"Low Grade Fibromyxoid Sarcoma","ValueMeaning":{"publicId":"3123924","version":"1","preferredName":"Low Grade Fibromyxoid Sarcoma","longName":"3123924","preferredDefinition":"denoting slow growth; indolent.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004: A soft tissue neoplasm of uncertain lineage characterized by the presence of neoplastic spindle-shaped to round cells in a fibromyxoid stroma. Metaplastic bone formation may or may not be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibromyxoid Tumor","conceptCode":"C66760","definition":"A soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle-shaped to round cells in a fibromyxoid stroma. Metaplastic bone formation may or may not be present.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44EC-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-01BD-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8825/3","valueDescription":"Low grade myofibroblastic sarcoma","ValueMeaning":{"publicId":"3123922","version":"1","preferredName":"Low grade myofibroblastic sarcoma","longName":"3123922","preferredDefinition":"Low grade myofibroblastic sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44C4-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-01D1-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8711/3","valueDescription":"Malignant Glomus Tumor","ValueMeaning":{"publicId":"3123921","version":"1","preferredName":"Malignant Glomus Tumor","longName":"3123921","preferredDefinition":"A very rare morphologic variant of glomus tumor with a size greater than 2 cm.  The tumor arises in subfascial or visceral tissues. It characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both.  It has an aggressive clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Glomus Tumor","conceptCode":"C4221","definition":"A very rare morphologic variant of glomus tumor with a size greater than 2 cm.  The tumor arises in subfascial or visceral tissues. It is characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both.  It has an aggressive clinical course.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44A1-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-01F9-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8990/3","valueDescription":"Malignant mesenchymoma","ValueMeaning":{"publicId":"2568849","version":"1","preferredName":"Malignant mesenchymoma","longName":"2568849","preferredDefinition":"Malignant mesenchymoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-020D-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9540/3","valueDescription":"Maligant peripheral nerve sheath tumor","ValueMeaning":{"publicId":"2568868","version":"1","preferredName":"Maligant peripheral nerve sheath tumor","longName":"2568868","preferredDefinition":"Maligant peripheral nerve sheath tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA11-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0221-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8815/3","valueDescription":"Malignant Solitary Fibrous Tumor","ValueMeaning":{"publicId":"3123919","version":"1","preferredName":"Malignant Solitary Fibrous Tumor","longName":"3123919","preferredDefinition":"A malignant neoplasm of probable fibroblastic derivation. It is characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Solitary Fibrous Tumor","conceptCode":"C6894","definition":"A malignant neoplasm of probable fibroblastic derivation. It is characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change and high mitotic activity.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-447B-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0235-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9240/3","valueDescription":"Mesenchymal chondrosarcoma","ValueMeaning":{"publicId":"2568864","version":"1","preferredName":"Mesenchymal chondrosarcoma","longName":"2568864","preferredDefinition":"Mesenchymal chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0249-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8855/3","valueDescription":"Mixed Liposarcoma","ValueMeaning":{"publicId":"3123917","version":"1","preferredName":"Mixed Liposarcoma","longName":"3123917","preferredDefinition":"A malignant neoplasm characterized by the presence of a combination of liposarcomatous morphologic subtypes: myxoid/round cell and well differentiated/dedifferentiated liposarcoma or myxoid/round cell and pleomorphic liposarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Liposarcoma","conceptCode":"C4253","definition":"A malignant neoplasm characterized by the presence of a combination of liposarcomatous morphologic subtypes: myxoid/round cell and well differentiated/dedifferentiated liposarcoma or myxoid/round cell and pleomorphic liposarcoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4455-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-025D-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8811/3","valueDescription":"Myxofibrosarcoma","ValueMeaning":{"publicId":"2568826","version":"1","preferredName":"Myxofibrosarcoma","longName":"2568826","preferredDefinition":"Myxofibrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0271-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8852/3","valueDescription":"Myxoid liposarcoma","ValueMeaning":{"publicId":"2568821","version":"1","preferredName":"Myxoid liposarcoma","longName":"2568821","preferredDefinition":"Myxoid liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0285-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9180/3","valueDescription":"Osteosarcoma NOS","ValueMeaning":{"publicId":"2568861","version":"1","preferredName":"Osteosarcoma NOS","longName":"2568861","preferredDefinition":"Osteosarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-02C1-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9135/1","valueDescription":"Papillary Intralymphatic Angioendothelioma","ValueMeaning":{"publicId":"3123911","version":"1","preferredName":"Papillary Intralymphatic Angioendothelioma","longName":"3123911","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Intralymphatic Angioendothelioma","conceptCode":"C7526","definition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-43E3-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-02D5-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9192/3","valueDescription":"Parosteal (juxtacortical) osteosarcoma","ValueMeaning":{"publicId":"2568855","version":"1","preferredName":"Parosteal (juxtacortical) osteosarcoma","longName":"2568855","preferredDefinition":"Parosteal (juxtacortical) osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA04-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-02E9-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9193/3","valueDescription":"Periosteal osteosarcoma","ValueMeaning":{"publicId":"2568856","version":"1","preferredName":"Periosteal osteosarcoma","longName":"2568856","preferredDefinition":"Periosteal osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA05-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-02FD-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8854/3","valueDescription":"Pleomorphic liposarcoma","ValueMeaning":{"publicId":"2568822","version":"1","preferredName":"Pleomorphic liposarcoma","longName":"2568822","preferredDefinition":"Pleomorphic liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0311-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8901/3","valueDescription":"Pleomorphic rhabdomyosarcoma","ValueMeaning":{"publicId":"2568835","version":"1","preferredName":"Pleomorphic rhabdomyosarcoma","longName":"2568835","preferredDefinition":"Pleomorphic rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0325-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9135/1","valueDescription":"Retiform Hemangioendothelioma","ValueMeaning":{"publicId":"3123906","version":"1","preferredName":"Retiform Hemangioendothelioma","longName":"3123906","preferredDefinition":"An intermediate, locally aggressive blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retiform Hemangioendothelioma","conceptCode":"C27511","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4371-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0339-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8853/3","valueDescription":"Round Cell Liposarcoma","ValueMeaning":{"publicId":"3113270","version":"1","preferredName":"Round Cell Liposarcoma","longName":"3113270","preferredDefinition":"A poorly differentiated liposarcoma, characterized by the presence of solid sheets of primitive round mesenchymal cells and the absence of myxoid stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Round Cell Liposarcoma","conceptCode":"C4252","definition":"A poorly differentiated liposarcoma, characterized by the presence of solid sheets of primitive round mesenchymal cells and the absence of myxoid stroma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899A6C2D-CCCA-EBDD-E040-BB89AD432D12","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-034D-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8810/3","valueDescription":"Sclerosing Epithelioid Fibrosarcoma","ValueMeaning":{"publicId":"3123904","version":"1","preferredName":"Sclerosing Epithelioid Fibrosarcoma","longName":"3123904","preferredDefinition":"A well-circumscribed rare morphologic variant of fibrosarcoma, that arises from the soft tissues. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sclerosing Epithelioid Fibrosarcoma","conceptCode":"C49027","definition":"A well-circumscribed malignant fibroblastic neoplasm that usually arises from the soft tissue. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4336-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0361-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9180/3","valueDescription":"Secondary Osteosarcoma","ValueMeaning":{"publicId":"3123902","version":"1","preferredName":"Secondary Osteosarcoma","longName":"3123902","preferredDefinition":"An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Osteosarcoma","conceptCode":"C53704","definition":"An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4310-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0375-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9185/3","valueDescription":"Small cell osteosarcoma","ValueMeaning":{"publicId":"2568860","version":"1","preferredName":"Small cell osteosarcoma","longName":"2568860","preferredDefinition":"Small cell osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0389-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8910/3","valueDescription":"Spindle cell rhabdomyosarcoma","ValueMeaning":{"publicId":"2568833","version":"1","preferredName":"Spindle cell rhabdomyosarcoma","longName":"2568833","preferredDefinition":"Spindle cell rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-039D-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9194/3","valueDescription":"Surface osteosarcoma, high-grade","ValueMeaning":{"publicId":"2568857","version":"1","preferredName":"Surface osteosarcoma, high-grade","longName":"2568857","preferredDefinition":"Surface osteosarcoma, high-grade","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA06-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-03B1-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9040/3","valueDescription":"Synovial sarcoma","ValueMeaning":{"publicId":"2568843","version":"1","preferredName":"Synovial sarcoma","longName":"2568843","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-03C5-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9183/3","valueDescription":"Telangiectatic osteosarcoma","ValueMeaning":{"publicId":"2568858","version":"1","preferredName":"Telangiectatic osteosarcoma","longName":"2568858","preferredDefinition":"Telangiectatic osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA07-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-03D9-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"Radiation-induced sarcoma","valueDescription":"Radiation-Related Neoplasm Sarcoma","ValueMeaning":{"publicId":"3123909","version":"1","preferredName":"Radiation-Related Neoplasm Sarcoma","longName":"3123909","preferredDefinition":"Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation-Related Neoplasm","conceptCode":"C3265","definition":"A neoplasm that develops as a result of exposure to radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-43BD-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FB3B-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"Radiation-Related Angiosarcoma","valueDescription":"Radiation-Related Angiosarcoma","ValueMeaning":{"publicId":"3123908","version":"1","preferredName":"Radiation-Related Angiosarcoma","longName":"3123908","preferredDefinition":"A malignant vascular neoplasm arising in an anatomic site exposed to radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation-Related Angiosarcoma","conceptCode":"C27513","definition":"A malignant vascular neoplasm arising in an anatomic site exposed to radiation therapy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4397-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FB45-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8830/3","valueDescription":"Undifferentiated pleomorphic sarcoma/\"MFH\"","ValueMeaning":{"publicId":"2568828","version":"1","preferredName":"Undifferentiated pleomorphic sarcoma/\"MFH\"","longName":"2568828","preferredDefinition":"Undifferentiated pleomorphic sarcoma/\"MFH\"","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-03ED-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8980/3","valueDescription":"Uterine carcinosarcoma (mixed mesodermal sarcoma)","ValueMeaning":{"publicId":"2568852","version":"1","preferredName":"Uterine carcinosarcoma (mixed mesodermal sarcoma)","longName":"2568852","preferredDefinition":"Uterine carcinosarcoma (mixed mesodermal sarcoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA01-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0401-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"Sarcoma NOS","valueDescription":"Sarcoma NOS","ValueMeaning":{"publicId":"2568850","version":"1","preferredName":"Sarcoma NOS","longName":"2568850","preferredDefinition":"Sarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FB6D-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8890/3","valueDescription":"Uterine leiomyosarcoma","ValueMeaning":{"publicId":"2568851","version":"1","preferredName":"Uterine leiomyosarcoma","longName":"2568851","preferredDefinition":"Uterine leiomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA00-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0415-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8851/3","valueDescription":"Well differentiated liposarcoma","ValueMeaning":{"publicId":"2568819","version":"1","preferredName":"Well differentiated liposarcoma","longName":"2568819","preferredDefinition":"Well differentiated liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB355-0429-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9252/3","valueDescription":"Malignant giant cell tumor of tendon sheath","ValueMeaning":{"publicId":"3139321","version":"1","preferredName":"Malignant giant cell tumor of tendon sheath","longName":"3139321","preferredDefinition":"Malignant giant cell tumor of tendon sheath","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B21579-3955-F388-E040-BB89AD4336E2","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-396E-F388-E040-BB89AD4336E2","beginDate":"2010-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"8832/3","valueDescription":"Dermatofibrosarcoma protuberans","ValueMeaning":{"publicId":"2568824","version":"1","preferredName":"Dermatofibrosarcoma protuberans","longName":"2568824","preferredDefinition":"Dermatofibrosarcoma protuberans","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-3982-F388-E040-BB89AD4336E2","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"8842/0","valueDescription":"Ossifying Fibromyxoid Tumor","ValueMeaning":{"publicId":"3123913","version":"1","preferredName":"Ossifying Fibromyxoid Tumor","longName":"3123913","preferredDefinition":"A rare soft tissue neoplasm of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ossifying Fibromyxoid Tumor","conceptCode":"C6582","definition":"A rare soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4409-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-3996-F388-E040-BB89AD4336E2","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"9140/3","valueDescription":"Kaposi sarcoma","ValueMeaning":{"publicId":"2568842","version":"1","preferredName":"Kaposi sarcoma","longName":"2568842","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"UMLLOADER_COPPAPRD","dateModified":"2009-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-39AA-F388-E040-BB89AD4336E2","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"9250/3","valueDescription":"Malignant giant cell tumor of bone","ValueMeaning":{"publicId":"3139322","version":"1","preferredName":"Malignant giant cell tumor of bone","longName":"3139322","preferredDefinition":"Malignant giant cell tumor of bone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B21579-39B4-F388-E040-BB89AD4336E2","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-39CD-F388-E040-BB89AD4336E2","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"9260/3","valueDescription":"Extraskeletal Ewing's/PNET","ValueMeaning":{"publicId":"2568847","version":"1","preferredName":"Extraskeletal Ewing's/PNET","longName":"2568847","preferredDefinition":"Extraskeletal Ewing's/PNET","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B21579-39E1-F388-E040-BB89AD4336E2","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-20","modifiedBy":"ONEDATA","dateModified":"2010-09-20","deletedIndicator":"No"},{"value":"8920/3","valueDescription":"Alveolar rhabdomyosarcoma","ValueMeaning":{"publicId":"2568834","version":"1","preferredName":"Alveolar rhabdomyosarcoma","longName":"2568834","preferredDefinition":"Alveolar rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FD3C-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9581/3","valueDescription":"Alveolar soft part sarcoma","ValueMeaning":{"publicId":"2568846","version":"1","preferredName":"Alveolar soft part sarcoma","longName":"2568846","preferredDefinition":"Alveolar soft part sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FD50-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9120/3","valueDescription":"Angiosarcoma","ValueMeaning":{"publicId":"2568840","version":"1","preferredName":"Angiosarcoma","longName":"2568840","preferredDefinition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiosarcoma","conceptCode":"C3088","definition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FD64-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8910/3","valueDescription":"Botryoid rhabdomyosarcoma","ValueMeaning":{"publicId":"2568832","version":"1","preferredName":"Botryoid rhabdomyosarcoma","longName":"2568832","preferredDefinition":"Botryoid rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9ED-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FD78-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9220/3","valueDescription":"Chondrosarcoma","ValueMeaning":{"publicId":"2568862","version":"1","preferredName":"Chondrosarcoma","longName":"2568862","preferredDefinition":"Chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FD8C-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9370/3","valueDescription":"Chordoma","ValueMeaning":{"publicId":"2568867","version":"1","preferredName":"Chordoma","longName":"2568867","preferredDefinition":"Chordoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA10-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FDA0-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9242/3","valueDescription":"Clear cell chondrosarcoma","ValueMeaning":{"publicId":"2568865","version":"1","preferredName":"Clear cell chondrosarcoma","longName":"2568865","preferredDefinition":"Clear cell chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FDB4-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9044/3","valueDescription":"Clear cell sarcoma (MMSP)","ValueMeaning":{"publicId":"2568845","version":"1","preferredName":"Clear cell sarcoma (MMSP)","longName":"2568845","preferredDefinition":"Clear cell sarcoma (MMSP)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FDC8-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9130/1","valueDescription":"Composite Hemangioendothelioma","ValueMeaning":{"publicId":"3123863","version":"1","preferredName":"Composite Hemangioendothelioma","longName":"3123863","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Composite Hemangioendothelioma","conceptCode":"C45475","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3BC0-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FDDC-62B1-E040-BB89AD4341E3","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9180/3","valueDescription":"Conventional central osteosarcoma","ValueMeaning":{"publicId":"2568854","version":"1","preferredName":"Conventional central osteosarcoma","longName":"2568854","preferredDefinition":"Conventional central osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA03-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FDF0-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"9343/3","valueDescription":"Dedifferentiated chondrosarcoma","ValueMeaning":{"publicId":"2568863","version":"1","preferredName":"Dedifferentiated chondrosarcoma","longName":"2568863","preferredDefinition":"Dedifferentiated chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE04-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8858/3","valueDescription":"Dedifferentiated liposarcoma","ValueMeaning":{"publicId":"2568820","version":"1","preferredName":"Dedifferentiated liposarcoma","longName":"2568820","preferredDefinition":"Dedifferentiated liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE18-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8806/3","valueDescription":"Desmoplastic small cell tumor","ValueMeaning":{"publicId":"2568848","version":"1","preferredName":"Desmoplastic small cell tumor","longName":"2568848","preferredDefinition":"Desmoplastic small cell tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE40-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"},{"value":"8910/3","valueDescription":"Embryonal rhabdomyosarcoma","ValueMeaning":{"publicId":"2568831","version":"1","preferredName":"Embryonal rhabdomyosarcoma","longName":"2568831","preferredDefinition":"Embryonal rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDDB354-FE54-62B1-E040-BB89AD4341E3","beginDate":"2004-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3124054","version":"1","preferredName":"Sarcoma Histologic And Cell Differentiation ICD-O-3_Code Code","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004:Of or relating to histology.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs.:Indicates the matching ICD-O-3 code for the NCI Thesaurus concept.:A system of numbered categories for representation of data.","longName":"3124054v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cell Differentiation Process","conceptCode":"C16399","definition":"Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"ICD-O-3_Code","conceptCode":"C66766","definition":"Indicates the matching ICD-O-3 code for the NCI Thesaurus concept.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDDB354-F8F8-62B1-E040-BB89AD4341E3","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"ONEDATA","dateModified":"2010-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDDB354-F909-62B1-E040-BB89AD4341E3","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"REEVESD","dateModified":"2010-10-31","changeDescription":"added 3 new values specific for GIST trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3124057","version":"1","longName":"Sarcoma Database","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3124058","version":"1","longName":"Sarcoma Database CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the ICD-O-3 code base","type":"Preferred Question Text","description":"What is the ICD-O-3 code based on the WHO histologic diagnosis?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BFE64A9-D01A-AC08-E040-BB89AD432BDE","latestVersionIndicator":"Yes","beginDate":"2010-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-22","modifiedBy":"REEVESD","dateModified":"2011-02-28","changeDescription":"Curated for the Sarcoma Database","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}